XML 141 R133.htm IDEA: XBRL DOCUMENT v3.22.0.1
Restatement of Previously Issued Financial Statements - Consolidated Statements of Cash Flows (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Feb. 28, 2021
Jul. 31, 2021
Jan. 31, 2021
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Dec. 31, 2019
Error Corrections and Prior Period Adjustments Restatement [Line Items]                          
Net loss       $ 28,424 $ (131,567) $ (55,951) $ (181,986) $ (25,281) $ (129,633) $ (159,094) $ (336,900)    
Depreciation and amortization       130,683     68,614     392,513 176,200    
Bad debt expense                   6,832 1,830    
Deferred income tax benefit                   (11,076) (7,420)    
Share-based Compensation                   3,054 26,344    
Noncash Impairment, Leases       757     110     50,979 4,880    
Gain (Loss) on Foreign Currency Forward Contracts                   4,026 (2,903)    
Mark to Market Loss on Contingent Shares                   (25,085) 30,839    
Fair Value Adjustment of Warrants       (83,013)     144,753     (113,207) 224,175    
Increase (Decrease) in Deferred Charges                   9,050 3,140    
Other Noncash Income (Expense)                   3,565 (3,902)    
Increase (Decrease) in Accounts Receivable                   114,038 129,398    
Increase (Decrease) in Prepaid Expense                   (887) (13,335)    
Increase (Decrease) in Other Noncurrent Assets                   60,749 62,818    
Accounts payable                   13,550 (8,394)    
Accrued expenses and other current liabilities                   90,439 (65,062)    
Deferred revenues                   (116,312) (93,926)    
Operating lease right of use assets                   16,838 5,826    
Operating lease liabilities                   (37,362) (6,611)    
Other liabilities                   2,905 2,077    
Net Cash Provided by (Used in) Operating Activities                   305,515 128,022    
Capital expenditures                   (86,197) (78,597)    
Payments to Acquire Businesses, Net of Cash Acquired                   (14,314) (885,323)    
Net Cash Provided by (Used in) Investing Activities                   (100,511) (966,151)    
Proceeds from Issuance of Long-term Debt                   2,000,000      
Extinguishment of debt                   (157,424)      
Principal payments on term loan                   (21,450) (9,450)    
Repayments of Long-term Lines of Credit                   0 (65,000)    
Payments of Debt Issuance Costs                   (7,471) (5,267)    
Payment for Contingent Consideration Liability, Financing Activities                   0 (4,115)    
Proceeds from Issuance of Convertible Preferred Stock                   1,392,671      
Proceeds from issuance of ordinary shares                   728,080 843,752    
Payments for Repurchase of Equity                   (65,215)      
Payments of Dividends                   (1)      
Proceeds from warrant exercises                   0 277,526    
Proceeds from stock options exercised                   17,250 1,307    
Payments related to tax withholding for stock-based compensation                   (21,455) (28,674)    
Net cash provided by financing activities                   3,864,985 1,370,079    
Effects of exchange rates                   (4,860) (6,447)    
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect                   4,065,129 525,503    
Cash and cash equivalents       2,479,880     601,075     2,479,880 601,075 $ 257,730 $ 76,130
Restricted cash       1,857,657     567     1,857,657 567 14,678 9
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents       4,337,537     601,642     4,337,537 601,642 272,408 76,139
Cash paid for interest                   97,401 61,796    
Cash paid for income tax                   22,387 20,147    
Capital expenditures included in accounts payable                   6,612 922    
Issuance of ordinary shares, net           $ 105,509   $ 304,030 $ 539,714        
Treasury Stock, Retired, Cost Method, Amount         $ 0         (5,117,380)      
Stock Issued During Period, Value, Stock Dividend   $ 16,141   16,141                  
Preferred Stock, Amount of Preferred Dividends in Arrears       6,289                  
Stock Issued                   62,724      
DRG                          
Error Corrections and Prior Period Adjustments Restatement [Line Items]                          
Value of stock issued $ 61,619                 61,619      
CPA Global                          
Error Corrections and Prior Period Adjustments Restatement [Line Items]                          
Value of stock issued     $ 43,890                    
Affiliated Entity                          
Error Corrections and Prior Period Adjustments Restatement [Line Items]                          
Issuance of ordinary shares, net       5,052,165                  
Previously Reported                          
Error Corrections and Prior Period Adjustments Restatement [Line Items]                          
Net loss       23,312     (37,233)     (82,852) (112,725)    
Depreciation and amortization                   392,513 176,200    
Bad debt expense                   6,832 1,830    
Deferred income tax benefit                   (11,084) (7,420)    
Share-based Compensation                   36,944 26,344    
Noncash Impairment, Leases                   60,232 4,880    
Gain (Loss) on Foreign Currency Forward Contracts                   4,026 2,903    
Mark to Market Loss on Contingent Shares                   (34,503) 30,839    
Fair Value Adjustment of Warrants       (83,013)     0     (113,207) 0    
Increase (Decrease) in Deferred Charges                   9,050 3,140    
Other Noncash Income (Expense)                   3,565 (3,902)    
Increase (Decrease) in Accounts Receivable                   114,038 129,398    
Increase (Decrease) in Prepaid Expense                   (887) (13,335)    
Increase (Decrease) in Other Noncurrent Assets                   60,749 62,818    
Accounts payable                   13,550 (8,394)    
Accrued expenses and other current liabilities                   (14,208)      
Deferred revenues                   (116,312) (93,926)    
Operating lease right of use assets                   16,838 5,826    
Operating lease liabilities                   (37,362) (6,611)    
Other liabilities                   (2,407) 2,077    
Net Cash Provided by (Used in) Operating Activities                   305,515 128,022    
Capital expenditures                   (86,197) (78,597)    
Payments to Acquire Businesses, Net of Cash Acquired                   (14,314) (885,323)    
Net Cash Provided by (Used in) Investing Activities                   (100,511) (966,151)    
Proceeds from Issuance of Long-term Debt                   2,000,000      
Extinguishment of debt                   (157,424)      
Principal payments on term loan                   (21,450) (9,450)    
Repayments of Long-term Lines of Credit                   0 (65,000)    
Payments of Debt Issuance Costs                   (7,471) (5,267)    
Payment for Contingent Consideration Liability, Financing Activities                   0 (4,115)    
Proceeds from Issuance of Convertible Preferred Stock                   1,392,671      
Proceeds from issuance of ordinary shares                   728,080 843,752    
Payments for Repurchase of Equity                   (65,215)      
Payments of Dividends                   (1)      
Proceeds from warrant exercises                   0      
Proceeds from stock options exercised                   17,250      
Payments related to tax withholding for stock-based compensation                   (21,455) (28,674)    
Net cash provided by financing activities                   3,864,985 1,370,079    
Effects of exchange rates                   (4,860) (6,447)    
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect                   4,065,129 525,503    
Cash and cash equivalents       2,479,880     601,075     2,479,880 601,075 257,730 76,130
Restricted cash       1,854,257     567     1,854,257 567 11,278 9
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents       4,334,137     601,642     4,334,137 601,642 269,008 $ 76,139
Cash paid for interest                   97,401 61,796    
Cash paid for income tax                   22,387 20,147    
Capital expenditures included in accounts payable                   6,612 922    
Issuance of ordinary shares, net       5,052,165                  
Treasury Stock, Retired, Cost Method, Amount                   (5,117,380)      
Value of stock issued     43,890             61,619      
Stock Issued During Period, Value, Stock Dividend       16,141                  
Preferred Stock, Amount of Preferred Dividends in Arrears       6,289                  
Stock Issued                   62,724      
Revision of Prior Period, Error Correction, Adjustment                          
Error Corrections and Prior Period Adjustments Restatement [Line Items]                          
Net loss       5,112     (144,753)     (76,242) (224,175)    
Depreciation and amortization                   0      
Bad debt expense                   0      
Deferred income tax benefit                   8      
Share-based Compensation                   (33,890)      
Noncash Impairment, Leases                   (9,253)      
Gain (Loss) on Foreign Currency Forward Contracts                   0      
Mark to Market Loss on Contingent Shares                   9,418      
Fair Value Adjustment of Warrants       0     $ 144,753     0 $ 224,175    
Increase (Decrease) in Deferred Charges                   0      
Other Noncash Income (Expense)                   0      
Increase (Decrease) in Accounts Receivable                   0      
Increase (Decrease) in Prepaid Expense                   0      
Increase (Decrease) in Other Noncurrent Assets                   0      
Accounts payable                   0      
Accrued expenses and other current liabilities                   104,647      
Deferred revenues                   0      
Operating lease right of use assets                   0      
Operating lease liabilities                   0      
Other liabilities                   5,312      
Net Cash Provided by (Used in) Operating Activities                   0      
Capital expenditures                   0      
Payments to Acquire Businesses, Net of Cash Acquired                   0      
Net Cash Provided by (Used in) Investing Activities                   0      
Proceeds from Issuance of Long-term Debt                   0      
Extinguishment of debt                   0      
Principal payments on term loan                   0      
Repayments of Long-term Lines of Credit                   0      
Payments of Debt Issuance Costs                   0      
Payment for Contingent Consideration Liability, Financing Activities                   0      
Proceeds from Issuance of Convertible Preferred Stock                   0      
Proceeds from issuance of ordinary shares                   0      
Payments for Repurchase of Equity                   0      
Payments of Dividends                   0      
Proceeds from warrant exercises                   0      
Proceeds from stock options exercised                   0      
Payments related to tax withholding for stock-based compensation                   0      
Net cash provided by financing activities                   0      
Effects of exchange rates                   0      
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect                   0      
Cash and cash equivalents       0           0   0  
Restricted cash       3,400           3,400   3,400  
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents       3,400           3,400   $ 3,400  
Cash paid for interest                   0      
Cash paid for income tax                   0      
Capital expenditures included in accounts payable                   0      
Issuance of ordinary shares, net       0                  
Treasury Stock, Retired, Cost Method, Amount                   0      
Value of stock issued     $ 0             0      
Stock Issued During Period, Value, Stock Dividend       0                  
Preferred Stock, Amount of Preferred Dividends in Arrears       $ 0                  
Stock Issued                   $ 0